Specialty pharmacy costs have consistently increased at a higher rate than overall healthcare and pharmacy costs, and this trend is expected to continue. High-cost drugs entering the market typically have large variability in uptake and create significant uncertainty, yet it is challenging to know when therapeutic alternatives and other cost-saving measures are viable.